SAN FRANCISCO, California (October 2, 2025) — Grove AI, a company advancing the next generation of clinical trials with agentic artificial intelligence (AI), is honored to be nominated for the California Life Sciences (CLS) 2025 Pantheon Awards.

On Thursday, November 6, 2025, Grove AI will join leading innovators at the 22nd Annual Pantheon Awards ceremony, celebrating companies and leaders driving life sciences innovation in California.

“Being recognized alongside such an incredible group of innovators is a true honor,” said Tran Le, Co-founder and CEO of Grove AI. “Our mission is to transform clinical trials with agentic AI, making them faster, more efficient, and more patient-centric.”

The Pantheon Awards spotlight the organizations shaping the future of biotechnology, pharmaceuticals, medical technology, and diagnostics.

For more information, visit CLS Pantheon Awards 2025.